Associated Papers
Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature.
Sepúlveda Palamara RA et al.
Expert Review of Hematology, 2024
Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification.
Martín Merinero H et al.
Blood, 2021
Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.
Geerlings MJ et al.
Clinical Genetics, 2018
29888403 (PubMed )
Supplement: CGE-94-330-s001.zip › Appendix_S1 › Table_S4.xlsx › CFH
Atypical Hemolytic Uremic Syndrome in Children Aged <2 Years.
Çakar N et al.
Nephron, 2018
Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
Levi C et al.
Transplantation, 2017
Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients.
Besbas N et al.
Bmc Nephrology, 2017
New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.
Rodriguez E et al.
Bioscience Reports, 2014
Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation.
Noris M et al.
Current Opinion in Nephrology and Hypertension, 2013
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
Fremeaux-Bacchi V et al.
Clinical Journal of the American Society of Nephrology : Cjasn, 2013
Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
Besbas N et al.
Pediatric Nephrology (berlin, Germany), 2013
Select a paper to view details